articleScience Translational MedicineFeb 15, 2012Closed access

MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways

Regulus Therapeutics (United States) · California Institute for Regenerative Medicine · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Scarring of the kidney is a major public health concern, directly promoting loss of kidney function. To understand the role of microRNA (miRNA) in the progression of kidney scarring in response to injury, we investigated changes in miRNA expression in two kidney fibrosis models and identified 24 commonly up-regulated miRNAs. Among them, miR-21 was highly elevated in both animal models and in human transplanted kidneys with nephropathy. Deletion of miR-21 in mice resulted in no overt abnormality. However, miR-21(-/-) mice suffered far less interstitial fibrosis in response to kidney injury, a phenotype duplicated in wild-type mice treated with anti-miR-21 oligonucleotides. Global derepression of miR-21 target…

No related works found for this paper.